Multiple antenna ablation apparatus and method

Information

  • Patent Grant
  • 6958062
  • Patent Number
    6,958,062
  • Date Filed
    Monday, November 3, 1997
    27 years ago
  • Date Issued
    Tuesday, October 25, 2005
    19 years ago
Abstract
A multiple antenna ablation apparatus includes an electromagnetic energy source, a trocar including a distal end, and a hollow lumen extending along a longitudinal axis of the trocar, and a multiple antenna ablation device with three or more antennas. The antennas are initially positioned in the trocar lumen as the trocar is introduced through tissue. At a selected tissue site the antennas are deployable from the trocar lumen in a lateral direction relative to the longitudinal axis. Each of the deployed antennas has an electromagnetic energy delivery surface of sufficient size to, (i) create a volumetric ablation between the deployed antennas, and (ii) the volumetric ablation is achieved without impeding out any of the deployed antennas when 5 to 200 watts of electromagnetic energy is delivered from the electromagnetic energy source to the multiple antenna ablation device. At least one cable couples the multiple antenna ablation device to the electromagnetic energy source.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


This invention relates generally to a multiple antenna ablation apparatus, and more particularly to a multiple antenna ablation apparatus where the size of the antennas' electromagnetic energy delivery surfaces is sufficient to prevent the apparatus from impeding out.


2. Description of the Related Art


Current open procedures for treatment of tumors are extremely disruptive and cause a great deal of damage to healthy tissue. During the surgical procedure, the physician must exercise care in not cutting the tumor in a manner that creates seeding of the tumor, resulting in metastasis. In recent years, development of products has been directed with an emphasis on minimizing the traumatic nature of traditional surgical procedures.


There has been a relatively significant amount of activity in the area of hyperthermia as a tool for treatment of tumors. It is known that elevating the temperature of tumors is helpful in the treatment and management of cancerous tissues. The mechanisms of selective treatment are not completely understood. However, four cellular effects of hyperthermia on cancerous tissue have been proposed, (i) changes in cell or nuclear membrane permeability or fluidity, (ii) cytoplasmic lysomal disintegration, causing release of digestive enzymes, (iii) protein thermal damage affecting cell respiration and the synthesis of DNA or RNA and (iv) potential excitation of immunologic systems. Treatment methods for applying heat to tumors include the use of direct contact radio-frequency (RF) applicators, microwave radiation, inductively coupled RF fields, ultrasound, and a variety of simple thermal conduction techniques.


Among the problems associated with all of these procedures is the requirement that highly localized heat be produced at depths of several centimeters beneath the surface of the skin. RF applications may be used at depth during surgery. However, the extent of localization is generally poor, with the result that healthy tissue may be harmed.


With RF lesion making, a high frequency alternating current flows from the electrode into the tissue. Ionic agitation is produced in the region of tissue about the electrode tip as the ions attempt to follow the directional variations of the alternating current. This agitation results in frictional heating so that the tissue about the electrode, rather than the electrode itself, is the primary source of heat. Tissue heat generated is produced by the flow of current through the electrical resistance offered by the tissue. The greater this resistance, the greater the heat generated.


Lesion size ultimately is governed by tissue temperature. Some idea of tissue temperature can be obtained by monitoring the temperature at an electrode or probe tip, usually with a thermistor. RF lesion heat is generated within the tissue, the temperature monitored will be the resultant heating of the electrode by the lesion. RF lesion heat is generated within the tissue, the temperature monitored is the resultant heating of the probe by the lesion. A temperature gradient extends from the lesion to the probe tip, so that the probe tip is slightly cooler than the tissue immediately surrounding it, but substantially hotter than the periphery of the lesion because of the rapid attenuation of heating effect with distance.


Current spreads out radially from the electrode tip, so that current density is greatest next to the tip, and decreases progressively at distances from it. The frictional heat produced from ionic agitation is proportional to current, i.e., ionic density. Therefore, the heating effect is greatest next to the electrode and decreases with distance from it. One consequence of this is that lesions can inadvertently be made smaller than anticipated for a given electrode size if the RF current level is too high. There must be time for equilibrium heating of tissue to be reached, especially at the center of the desired lesion volume. If the current density is too high, the tissue temperature next to the electrode rapidly exceeds desired levels and carbonization and boiling occurs in a thin tissue shell surrounding the electrode tip.


A need exists for a multiple antenna ablation apparatus with antenna electromagnetic energy delivery surface areas that are sufficiently large enough to prevent the apparatus from impeding out. There is a further need for a multiple antenna ablation apparatus with a sufficient number of antennas, providing a large enough electromagnetic energy delivery surface to a selected tissue site, to achieve volumetric ablation without impeding out the apparatus.


SUMMARY OF THE INVENTION

Accordingly, it is an object of the invention to provide an ablation device which includes multiple antennas that are deployed from a trocar into a selected tissue site.


Another object of the invention is to provide a multiple antenna ablation apparatus with electromagnetic energy delivery surfaces that are large enough to prevent the apparatus from impeding out.


Yet another object of the invention is to provide a multiple antenna ablation apparatus with a sufficient number of antennas to provide a large enough electromagnetic energy delivery from the antennas to prevent the apparatus from impeding out.


Still a further object of the invention is to provide a multiple antenna RF ablation apparatus with antenna electromagnetic energy delivery surfaces sufficiently large to prevent the apparatus from impeding out.


These and other objectives are achieved in a multiple antenna ablation apparatus. The apparatus includes an electromagnetic energy source, a trocar including a distal end, and a hollow lumen extending along a longitudinal axis of the trocar, and a multiple antenna ablation device with three or more antennas. The antennas are positionable in the trocar. At a selected tissue site the antennas are deployed from the trocar lumen in a lateral direction relative to the longitudinal axis. Each of the deployed antennas has an electromagnetic energy delivery surface of sufficient size to, (i) create a volumetric ablation between the deployed antennas, and (ii) the volumetric ablation is achieved without impeding out any of the deployed antennas when 5 to 200 watts of electromagnetic energy is delivered from the electromagnetic energy source to the multiple antenna ablation device. At least one cable couples the multiple antenna ablation device to the electromagnetic energy source.


In another embodiment, a method for creating a volumetric ablation in a selected tissue mass provides a multiple antenna ablation apparatus including a trocar with a trocar lumen, a plurality of antennas deployable from the lumen, and an electromagnetic energy source coupled to the plurality of antennas. The trocar is inserted into the selected tissue mass. The plurality of antennas are positioned in the trocar lumen before and after introduction of the trocar through tissue. The plurality of antennas are advanced from the trocar lumen in a lateral direction relative to a longitudinal axis of the trocar into the selected tissue mass. 5 to 200 watts of electromagnetic energy is delivered from the electromagnetic energy source to the plurality of antennas without impeding out an antenna of the plurality of antennas. The volumetric ablation is created between the plurality of antennas. In various embodiments, the apparatus can include each of the antennas coupled to the electromagnetic energy source, only one antenna coupled to the electromagnetic energy source, or more than one antenna coupled to the electromagnetic energy source. The trocar has an outer diameter of no greater than 13 gauge, preferably no greater than 14 gauge, and still more preferably no more than 15 gauge.


The number of deployed antennas can be four, five, six or more. Some of the antennas can be deployed out of the distal end of the trocar, while other antennas may be deployed from ports formed in the trocar along its longitudinal axis. The antennas may be RF electrodes operating in a monopolar mode, bipolar mode, or switchable between the two.


At least one sensor, preferably a thermal sensor, can be positioned along an exterior surface of a deployed antenna. More than one antenna can include a sensor. An insulation layer may be positioned in a surrounding relationship around at least a portion of an exterior of the trocar. A distal end of the insulation at the distal end of the trocar can be removed. This creates an electromagnetic energy delivery surface at the trocar's distal end. The trocar then becomes at least partially an antenna.


The trocar lumen may be coupled to an infusion medium source and deliver an infusion medium to the selected tissue site. A cooling element can be coupled to at least one of the antennas. The cooling element can be a structure positioned in at least one of the antennas and include at least one channel configured to receive a cooling medium. The cooling medium can be recirculated through the channel.





BRIEF DESCRIPTION OF THE FIGURES

FIG. 1(a) is a perspective view of the multiple antenna ablation apparatus of the present invention illustrating a trocar and three laterally deployed antennas. FIG. 1(b) is a cross-sectional view illustrating the electrode advancement member at least partially positioned in the introducer of FIG. 1 (a).



FIG. 2 is a perspective view of a conic geometric ablation achieved with the apparatus of FIG. 1.



FIG. 3 is a perspective view of the multiple antenna ablation apparatus of the present invention with two antennas.



FIG. 4 is a perspective view illustrating three antennas creating a complete ablation volume.



FIG. 5 is a perspective view illustrating the positioning of the multiple antenna ablation apparatus in the center of a selected tissue mass, and the creation of a cylindrical ablation.


FIG. 6(a) is a perspective view of the multiple antenna ablation of the present invention illustrating two antennas which provide a retaining and gripping function.


FIG. 6(b) is a perspective view of the multiple antenna ablation of the present invention illustrating three secondary antennas which provide a retaining and gripping function.


FIG. 6(c) is a cross-sectional view of the apparatus of FIG. 6(b) taken along the lines 6(c)—6(c).



FIG. 7 is a perspective view of the multiple antenna ablation of the present invention illustrating the deployment of three secondary antennas from a distal end of the insulation sleeve surrounding the primary antenna.



FIG. 8 is a perspective view of the multiple antenna ablation of the present invention illustrating the deployment of two secondary antennas from the primary antenna, and the deployment of three secondary antennas from the distal end of the insulation sleeve surrounding the primary antenna.



FIG. 9 is a block diagram illustrating the inclusion of a controller, electromagnetic energy source and other electronic components of the present invention.



FIG. 10 is a block diagram illustrating an analog amplifier, analog multiplexer and microprocessor used with the present invention.



FIG. 11 is a perspective view of the multiple antenna ablation apparatus of the present invention with two antennas.





DETAILED DESCRIPTION

The present invention provides a multiple antenna ablation apparatus. The apparatus includes an electromagnetic energy source, a trocar including a distal end, and a hollow lumen extending along a longitudinal axis of the trocar, and a multiple antenna ablation device with three or more antennas. The antennas are initially positioned in the trocar lumen as the trocar is introduced through tissue. At a selected tissue site the antennas are deployable from the trocar lumen in a lateral direction relative to the longitudinal axis. Each of the deployed antennas has an electromagnetic energy delivery surface of sufficient size to, (i) create a volumetric ablation between the deployed antennas, and (ii) create the volumetric ablation without impeding out any of the deployed antennas when 5 to 200 watts of electromagnetic energy is delivered from the electromagnetic energy source to the multiple antenna ablation device. In other embodiments, 5 to 100 watts, 5 to 75 watts and 5 to 50 watts of electromagnetic energy is delivered to the deployed antennas from the electromagnetic energy source without impeding out the deployed antennas. At least one cable couples the multiple antenna ablation device to the electromagnetic energy source. For purposes of this specification the term “impeding out” means that a tissue area has become sufficiently desiccated or carbonized that the desiccated or carbonized tissue area has a resultant high electrical resistance that impairs the process of creating a coagulating lesion.


As shown in FIG. 1(a), multiple antenna ablation device 12 includes a trocar 14, and one or more antennas 16, which are typically electrodes. Antennas 16 can be positioned initially in a trocar lumen when trocar 14 is advanced through tissue and introduced through the trocar lumen after trocar is advanced through tissue. When trocar 14 reaches a selected tissue ablation site in a selected tissue mass, including but not limited to a solid lesion, antennas 16 are laterally deployed relative to the trocar's longitudinal axis from the trocar lumen into the selected tissue mass. Volumetric ablation proceeds from the interior of the selected tissue mass in a direction towards a periphery of the selected tissue mass.


Each antenna has a distal end 16′ which extends in a lateral direction relative to a longitudinal axis of trocar 14. Unless the distal ends 16′ have insulation, then their entire length of extension is an electromagnetic energy delivery surface which delivers electromagnetic energy to the selected tissue mass. The length and size of each electromagnetic energy delivery surface can be variable. Lengths of antennas 16 can be adjustable. Trocar 14 can be moved up and down, rotated about its longitudinal axis, and moved back and forth, in order to define, along with sensors, the periphery or boundary of the selected tissue mass, including but not limited to a tumor. This provides a variety of different geometries, not always symmetrical, that can be ablated. Volumetric ablation is defined as the creation of an ablation with a periphery formed between adjacent distal ends 16′. The volume of non-ablated tissue between adjacent distal ends 16′ is minimized. A variety of different geometric ablations are achieved including but not limited to spherical, semi-spherical, spheroid, triangular, semi-triangular, square, semi-square, rectangular, semi-rectangular, conical, semi-conical, quadrilateral, semi-quadrilateral, semi-quadrilateral, rhomboidal, semi-rhomboidal, trapezoidal, semi-trapezoidal, combinations of the preceding, geometries with non-planar sections or sides, free-form and the like.


In one embodiment, trocar 14 can have a sharpened distal end 14′ to assist introduction through tissue. Each antenna 16 has a distal end 16′ that can be constructed to be less structurally rigid than trocar 14. Distal end 16′ is the section of antenna 16 that is advanced from the lumen antenna 14 and into the selected tissue mass. Distal end is typically less structurally rigid that trocar 14. Structural rigidity is determined by, (i) choosing different materials for trocar 14 and distal end 16′ or some greater length of antenna 16, (ii) using the same material but having less of it for antenna 16 or distal end 16′, e.g., antenna 16 or distal end 16′ is not as thick as trocar 14, or (iii) including another material in trocar 14 or an antenna 16 to vary their structural rigidity. For purposes of this disclosure, structural rigidity is defined as the amount of deflection that an antenna has relative to its longitudinal axis. It will be appreciated that a given antenna will have different levels of rigidity depending on its length.


Antennas 16 can be made of a variety of conductive materials, both metallic and non-metallic. One suitable material is type 304 stainless steel of hypodermic quality. In some applications, all or a portion of secondary electrode 16 can be made of a shaped memory metal, such as NiTi, commercially available from Raychem Corporation, Menlo Park, Calif.


Each of the antennas 16 can have different lengths. The lengths can be determined by the actual physical length of an antenna 16, the length of an antenna electromagnetic energy delivery surface, and the length of an antenna 16 that is not covered by an insulator. Suitable lengths include but are not limited to 17.5 cm, 25.0 cm. and 30.0 cm. The actual length of an antenna 16 depends on the location of the selected tissue mass to be ablated, its distance from the skin, its accessibility as well as whether or not the physician chooses a laparoscopic, percutaneous or other procedure.


An insulation sleeve 18 may be positioned around an exterior of trocar 14 and/or antennas 16. All or some of insulation sleeves 18 may be adjustably positioned so that the length of an antenna electromagnetic energy delivery surface can be varied. Each insulation sleeve 18 surrounding a trocar 14 can include one or more apertures. This permits the introduction of a antenna 16 through trocar 14 and insulation sleeve 18.


In one embodiment, insulation sleeve 18 comprises a polyamide material. A sensor 24 may be positioned on top of polyimide insulation sleeve 18. The polyamide insulation sleeve 18 is semi-rigid. Sensor 24 can lay down substantially along the entire length of polyamide insulation sleeve 18. Trocar 14 is made of a stainless-steel hypodermic tubing. Antennas 16 have distal ends 16′ that are made of NiTi hypodermic tubing. A handle is included with markings to show the length of lateral deployment of antennas 16 from trocar 14. Fluid infusion is delivered through a Luer port at a side of the handle. Type-T thermocouples are positioned at distal ends 16′.


An electromagnetic energy source 20 is connected to multiple antenna device 12 with one or more cables 22. Electromagnetic energy source 20 can be an RF source, microwave source, short wave source, laser source and the like. Multiple antenna device 12 can be comprised of antennas 16 that are RF electrodes, microwave antennas, as well as combinations thereof. Electromagnetic energy source 20 may be a combination RF/microwave box. Further a laser optical fiber, coupled to a laser source 20 can be introduced through one or both of trocar 14 or a antenna 16. Trocar 14 and/or a secondary electrode 16 can be an arm for the purposes of introducing the optical fiber.


Antennas 16 are electromagnetically coupled to electromagnetic energy source 20. The coupling can be direct from electromagnetic energy source 20 to each antenna 16, or indirect by using a coilet, sleeve and the like which couples one or more antennas 16 to electromagnetic energy source 20. Electromagnetic energy can be delivered from one antenna 16 to another.


One or more sensors 24 may be positioned on at least a portion of interior or exterior surfaces of trocar 14, antenna 16 or insulation sleeve 18. Preferably sensors 24 are positioned at trocar distal end 14′, antenna distal end 16′ and insulation sleeve distal end 18′. Sensors 24 permit accurate measurement of temperature at a tissue site in order to determine, (i) the extent of ablation, (ii) the amount of ablation, (iii) whether or not further ablation is needed and (iv) the boundary or periphery of the ablated mass. Further, sensors 24 prevent nontargeted tissue from being destroyed or ablated.


Sensors 24 are of conventional design, including but not limited to thermistors, thermocouples, resistive wires, and the like. Suitable thermal sensors 24 include a T type thermocouple with copper constantene, J type, E type, K type, fiber optics, resistive wires, thermocouple IR detectors, and the like. It will be appreciated that sensors 24 need not be thermal sensors.


Sensors 24 measure temperature and/or impedance to permit monitoring and a desired level of ablation to be achieved without destroying too much tissue. This reduces damage to tissue surrounding the targeted mass to be ablated. By monitoring the temperature at various points within the interior of the selected tissue mass, a determination of the selected tissue mass periphery can be made, as well as a determination of when ablation is complete. If at any time sensor 24 determines that a desired ablation temperature is exceeded, then an appropriate feedback signal is received at electromagnetic energy source 20 which then regulates the amount of electromagnetic energy delivered to antennas 16.


Thus the geometry of the ablated mass is selectable and controllable. Any number of different ablation geometries can be achieved. Creation of different ablation geometries is dependent on the length of electromagnetic energy ablation delivery surfaces, the number of antennas, the size of the electromagnetic delivery surfaces, the amount of power delivered to the antennas, and the duration of time for power delivery to the antennas.


Antenna distal ends 16′ can be laterally deployed relative to a longitudinal axis of trocar 14 out of an aperture 26 formed in trocar 14. Aperture 26 is at distal end 14′ or formed in a side of an exterior of antenna 14.


In one embodiment, a method for creating a volumetric ablation in a selected tissue mass provides multiple antenna ablation apparatus 12 including trocar 14 with a trocar lumen, a plurality of antennas 16 deployable from the lumen, and an electromagnetic energy source 20 coupled to the plurality of antennas. Trocar 14 is inserted into the selected tissue mass with the plurality of antennas positioned in the trocar 14 lumen. The plurality of antennas 16 are advanced from the trocar lumen in a lateral direction relative to a longitudinal axis of trocar 14 into the selected tissue mass. 10 to 50 watts, preferably 10 to 30, and still more preferably 15 to 20 watts of electromagnetic energy is delivered from electromagnetic energy source 20 to the plurality of antennas 16 without impeding out an antenna of the plurality of antennas. The volumetric ablation is created between the plurality of antennas 16.


There is wide variation in the amount of deflection of antenna 16. For example, antenna 16 can be deflected a few degrees from the longitudinal axis of trocar 14, or antennas 16 can be deflected in any number of geometric configurations, including but not limited to a “J” hook. Further, antennas 16 are capable of being introduced from trocar 14 a few millimeters from trocar 14, or a much larger distance. A cam 25 or other device can be positioned within trocar 14 to advance and retract antenna 16 in and out of trocar 14.


As illustrated in FIG. 2, trocar 14 is introduced into a selected tissue mass 28. Three or more antennas 16 arc positioned within a trocar lumen as trocar 14 is introduced into and through the selected tissue mass. In various embodiments, 3, 4, 5, or 6 antennas 16 are introduced laterally through trocar 14. Subsequently, antenna distal end 16′ is advanced out of aperture 26 into selected tissue mass 28. Insulation sleeves 18 are adjusted for antennas 16. RF, microwave, short wave and the like energy is delivery to antenna 16 in a monopolar mode (RF), or alternatively, multiple antenna device 12 can be operated in a bipolar mode (RF). Multiple antenna device 12 can be switched between monopolar and bipolar operation and may have multiplexing capability between different antennas 16. Antenna distal ends 16′ is retracted back into trocar 14, and trocar is then rotated. Antenna distal end 16′ is then introduced into selected tissue mass 28. Antennas 16 may be introduced a short distance into selected tissue mass 28 to ablate a small area, e.g., 3 cm or less. It can then be advanced further into any number of times to create more ablation zones. Again, antenna distal end 16′ is retracted back into trocar 14, and trocar 14 can be, (i) rotated again, (ii) moved along a longitudinal axis of selected tissue mass 28 to begin another series of ablations with antenna distal ends 16′ being introduced and retracted in and out of trocar 14, or (iii) removed from selected tissue mass 28. A number of parameters permit ablation of selected tissue masses 28 of different sign and shapes including a series of ablations having antennas 16 with variable length electromagnetic energy delivery surfaces and the use of one or more sensors 24.


In FIG. 3, two antennas 16 are each deployed out of trocar distal end 14′ and introduced into selected tissue mass 28. Antennas 16 form a plane and the area of ablation extends between the electromagnetic energy delivery surfaces of antennas 16. Trocar 14 can be introduced in an adjacent relationship to selected tissue mass 28. This particular deployment is useful for small selected tissue masses 28, or where piercing selected tissue mass 28 is not desirable. Trocar 14 can be rotated, with antennas 16 retracted in the lumen of trocar 14, and another ablation volume defined between the antennas 16 is created. Further, trocar 14 can be withdrawn from its initial position adjacent to selected tissue mass 28, repositioned to another position adjacent to selected tissue mass 28, and antennas 16 deployed to begin another ablation cycle. Any variety of different positionings may be utilized to create a desired ablation geometry for selected tissue mass of different geometries and sizes.


In FIG. 4, three antennas 16 are introduced into selected tissue mass 28. The effect is the creation of a substantially complete ablation volume formed between antennas 16 with a minimal central core that is not ablated.


Referring now to FIG. 5, a center of selected tissue mass 28 is pierced by trocar 14, antennas 16 are laterally deployed and retracted, trocar 14 is rotated, antennas 16 are deployed and retracted, and so on until a cylindrical ablation volume is achieved. Multiple antenna device 12 can be operated in the bipolar mode between the two antennas 16, or between a antenna 16 and trocar 14. Alternatively, multiple antenna device 12 can be operated in a monopolar mode.


Antennas 16 can serve the additional function of anchoring multiple antenna device 12 in a selected mass, as illustrated in FIGS. 6(a) and 6(b). In FIG. 6(a) one or both antennas 16 are used to anchor and position trocar 14. Further, one or both antennas 16 are also used to ablate tissue. In FIG. 6(b), three antennas are deployed and anchor trocar 14.


FIG. 6(c) illustrates the infusion capability of multiple antenna device 12. Three antennas 16 are positioned in a central lumen 14″ of trocar 14. One or more of the antennas 16 can also include a central lumen coupled to an infusion source. Central lumen 14″ is coupled to an infusion source and delivers a variety of infusion mediums to selected places both within and outside of the targeted ablation mass. Suitable infusion mediums include but are not limited to, therapeutic agents, conductivity enhancement mediums, contrast agents or dyes, and the like. An example of a therapeutic agent is a chemotherapeutic agent.


As shown in FIG. 7, insulation sleeve 18 can include one or more lumens for receiving antennas 16 which are deployed out of an insulation sleeve distal end 18′. FIG. 8 illustrates two antennas 16 being introduced out of insulation sleeve distal end 18′, and two antennas 16 introduced through apertures 26 formed in trocar 14. As illustrated, antennas 16 introduced through apertures 26 provide an anchoring function. FIG. 8 illustrates that antennas 16 can have a variety of different geometric configurations in multiple antenna device 12.


In FIG. 11, two antennas 16 are each deployed out of distal end 14′ and introduced into selected tissue mass 28. Antennas 16 form a plane and the area of ablation extends between the electromagnetic energy delivery surfaces of antennas 16. Trocar 14 can be introduced in an adjacent relationship to selected tissue mass 28. This particular deployment is useful for small selected tissue masses 28, or where piercing selected tissue mass 28 is not desirable. Trocar 14 can be rotated, with antennas 16 retracted in the lumen of trocar 14, and another ablation volume defined between the antennas 16 is created. Further, trocar 14 can be withdrawn from its initial position adjacent to selected tissue mass 28, repositioned to another position adjacent to selected tissue mass 28, and antennas 16 deployed to begin another ablation cycle. Any variety of different positionings may be utilized to create a desired ablation geometry for selected tissue mass of different geometries and sizes.


A feedback control system 29 is connected to electromagnetic energy source 20, sensors 24 and antennas 16. Feedback control system 29 receives temperature or impedance data from sensors 24 and the amount of electromagnetic energy received by antennas 16 is modified from an initial setting of ablation energy output, ablation time, temperature, and current density (the “Four Parameters”). Feedback control system 29 can automatically change any of the Four Parameters. Feedback control system 29 can detect impedance or temperature and change any of the Four Parameters. Feedback control system 29 can include a multiplexer to multiplex different antennas, a temperature detection circuit that provides a control signal representative of temperature or impedance detected at one or more sensors 24. A microprocessor can be connected to the temperature control circuit.


The following discussion pertains particularly to the use of an RF energy source and RF electrodes. It will be appreciated that devices similar to those associated with RF multiple antenna device 12 can be utilized with laser optical fibers, microwave devices and the like.


Referring now to FIG. 9, all or portions of feedback control system 29 are illustrated. Current delivered through antennas 16 is measured by current sensor 30. Voltage is measured by voltage sensor 32. Impedance and power are then calculated at power and impedance calculation device 34. These values can then be displayed at user interface and display 36. Signals representative of power and impedance values are received by controller 38.


A control signal is generated by controller 38 that is proportional to the difference between an actual measured value, and a desired value. The control signal is used by power circuits 40 to adjust the power output in an appropriate amount in order to maintain the desired power delivered at antennas 16.


In a similar manner, temperatures detected at sensors 24 provide feedback for determining the extent of ablation, and when a completed ablation has reached the physical location of sensors 24. The actual temperatures are measured at temperature measurement device 42 and the temperatures are displayed at user interface and display 36. A control signal is generated by controller 38 that is proportional to the difference between an actual measured temperature, and a desired temperature. The control signal is used by power circuits 40 to adjust the power output in an appropriate amount in order to maintain the desired temperature delivered at the respective sensor 24. A multiplexer can be included to measure current, voltage and temperature, at the numerous sensors 24, and energy is delivered to antennas 16.


Controller 38 can be a digital or analog controller, or a computer with software. When controller 38 is a computer it can include a CPU coupled through a system bus. On this system can be a keyboard, a disk drive, or other non-volatile memory systems, a display, and other peripherals, as are known in the art. Also coupled to the bus are a program memory and a data memory.


User interface and display 36 includes operator controls and a display. Controller 38 can be coupled to imaging systems, including but not limited to ultrasound, CT scanners, X-ray, MRI, mammographic X-ray and the like. Further, direct visualization and tactile imaging can be utilized.


The output of current sensor 30 and voltage sensor 32 is used by controller 38 to maintain a selected power level at antennas 16. The amount of RF energy delivered controls the amount of power. A profile of power delivered can be incorporated in controller 38, and a preset amount of energy to be delivered can also be profiled.


Circuitry, software and feedback to controller 38 result in process control, and the maintenance of the selected power, and are used to change, (i) the selected power, including RF, microwave, laser and the like, (ii) the duty cycle (on-off and wattage), (iii) bipolar or monopolar energy delivery and (iv) infusion medium delivery, including flow rate and pressure. These process variables are controlled and varied, while maintaining the desired delivery of power independent of changes in voltage or current, based on temperatures monitored at sensors 24.


Referring now to FIG. 10, current sensor 30 and voltage sensor 32 are connected to the input of an analog amplifier 44. Analog amplifier 44 can be a conventional differential amplifier circuit for use with sensors 24. The output of analog amplifier 44 is sequentially connected by an analog multiplexer 46 to the input of A/D converter 48. The output of analog amplifier 44 is a voltage which represents the respective sensed temperatures. Digitized amplifier output voltages are supplied by A/D converter 48 to a microprocessor 50. Microprocessor 50 may be Model No. 68HCII available from Motorola. However, it will be appreciated that any suitable microprocessor or general purpose digital or analog computer can be used to calculate impedance or temperature.


Microprocessor 50 sequentially receives and stores digital representations of impedance and temperature. Each digital value received by microprocessor 50 corresponds to different temperatures and impedances.


Calculated power and impedance values can be indicated on user interface and display 36. Alternatively, or in addition to the numerical indication of power or impedance, calculated impedance and power values can be compared by microprocessor 50 with power and impedance limits. When the values exceed predetermined power or impedance values, a warning can be given on user interface and display 36, and additionally, the delivery of RF energy can be 10 reduced, modified or interrupted. A control signal from microprocessor 50 can modify the power level supplied by electromagnetic energy source 20.


The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents.

Claims
  • 1. A method of volumetric ablation of tumorous tissue, comprising: providing a tissue ablation apparatus comprising an elongated delivery device having a tissue piercing distal end and a proximal end, and at least one RF electrode having a tissue penetrating distal portion, said at least one RF electrode being pre-shaped to assume a curved shape and define an ablation volume when deployed; advancing the elongated delivery device to the selected tissue site, wherein said advancing is effective to place the distal end of the delivery device in or adjacent the tumorous tissue; deploying said at least one RF electrode from the distalmost end of the elongated delivery device; delivering energy to a selected tissue site through said at least one RF electrode to ablate said tissue; monitoring a temperature of said tissue using at least one sensor positioned on said at least one RF electrode, and modulating delivery of said energy when said temperature reaches a predetermined limit.
  • 2. The method of claim 1, wherein at least a portion of the RF electrode includes an insulator, the method further comprising: utilizing the insulator to define at least a portion of the ablation volume.
  • 3. The method of claim 1 further comprising adjusting, in response to said measured temperature, said energy level to maintain said temperature at a desired value.
  • 4. The method of claim 1, wherein said at least one sensor is positioned at said distal end of said at least one RF electrode.
  • 5. A method of ablating a tissue mass comprising: positioning in a patient an ablation apparatus comprising an elongated delivery device and a plurality of electrodes that are pre-shaped to assume a curved shape and define an ablation volume when deployed, wherein said positioning is effective to place the distal tip of the delivery device in or adjacent the tissue mass; deploying said plurality of electrodes from the distalmost end of the elongated delivery device, thus to define an ablation volume that includes the tissue mass; applying an ablating current to the deployed electrodes, wherein said tissue mass contained within the defined volume is ablated; monitoring a characteristic of said tissue mass using at least one sensor positioned on at least one of said electrodes as said tissue mass is being ablated; and controlling the extent of ablation in response to the characteristic detected at said at least one sensor.
  • 6. The method of claim 5 wherein said sensors are positioned at a distal end of said electrodes.
  • 7. The method of claim 5 further comprising infusing said tissue with an infusion medium.
  • 8. The method of claim 7, wherein said infusion medium is a chemotherapeutic agent.
  • 9. The method of claim 7, wherein said infusion medium is a conductivity enhancement medium.
  • 10. The method of claim 7, wherein at least one of said plurality of electrodes includes a lumen capable of being operatively coupled to an infusion source, and said method further includes infusing a liquid through said electrodes into the defined ablation volume prior to or during said ablating step.
  • 11. The method of claim 5, wherein said sensor is a thermal sensor and said detected characteristic is temperature.
  • 12. The method of claim 11 further comprising adjusting, in response to said monitored characteristic, said energy to maintain said characteristic at a desired value.
  • 13. The method of claim 12, wherein said energy source is a RF source and said electrode is a RF electrode.
  • 14. The method of claim 13, wherein said electrodes, when deployed, have an electromagnetic energy delivery surface of a size sufficient to create a volumetric ablation without impeding out any one of said deployed electrodes when 5 to 200 watts of electromagnetic energy is delivered.
  • 15. The method of claim 5, wherein said controlling step comprises ceasing said applying of energy in response to said characteristic.
  • 16. The method of claim 5, wherein said controlling step comprises modulating said applying of energy in response to said characteristic.
  • 17. The method of claim 5, wherein said ablation apparatus includes an insulator positioned in a surrounding relationship to at least a portion of one of (i) the elongated delivery device, or (ii) at least one of the plurality of electrodes.
  • 18. The method of claim 17, further including positioning said insulator over at least one of the plurality of electrodes to produce a selectable energy delivery surface.
  • 19. The method of claim 5, wherein said detected characteristic is impedance.
  • 20. The method of claim 5, further including localizing the tissue mass by a process selected from the group consisting of ultrasound, computerized tomography scanning, X-ray, magnetic resonance imaging, and electromagnetic imaging.
  • 21. The method of claim 5, wherein said applying an ablating current comprises applying an RF current.
  • 22. The method of claim 5, wherein said applying an ablating current comprises applying a microwave current.
REFERENCE TO RELATED APPLICATION

This application is a continuation-in-part of U.S. patent application Ser. No. 08/605,323, filed Feb. 14, 1996, now U.S. Pat. No. 5,728,143, which is a continuation-in-part of U.S. patent application Ser. No. 08/515,379, filed Aug. 15, 1995, now U.S. Pat. No. 5,683,384, which is a continuation-in-part of U.S. Pat. application Ser. No. 08/290,031, filed Aug. 12, 1994, now U.S. Pat. No. 5,536,267 which is a continuation-in-part of U.S. patent application Ser. No. 08/148,439, filed Nov. 8, 1993, now U.S. Pat. No. 5,458,597, each of which are incorporated herein by reference.

US Referenced Citations (245)
Number Name Date Kind
3474777 Figge et al. Oct 1969 A
3834392 Lampman et al. Sep 1974 A
3858586 Lessen Jan 1975 A
3987795 Morrison, Jr. Oct 1976 A
3991770 LeVeen Nov 1976 A
4011872 Komiya Mar 1977 A
4016881 Rioux et al. Apr 1977 A
4016886 Doss Apr 1977 A
4026301 Friedman et al. May 1977 A
4033351 Hetzel Jul 1977 A
4043342 Morrison, Jr. Aug 1977 A
4074718 Morrison, Jr. Feb 1978 A
4080959 Leveen Mar 1978 A
4085756 Weaver Apr 1978 A
4095602 Leveen Jun 1978 A
4119102 LeVeen Oct 1978 A
4121592 Whalley Oct 1978 A
4140130 Storm, III Feb 1979 A
4154246 LeVeen May 1979 A
4230129 LeVeen Oct 1980 A
4237898 Whalley Dec 1980 A
4269174 Adair May 1981 A
4285346 Armitage Aug 1981 A
4289135 Nordensrom et al. Sep 1981 A
4290435 Waggott Sep 1981 A
4303636 Gordon Dec 1981 A
4331654 Morris May 1982 A
4337760 Rubin Jul 1982 A
4345588 Widder et al. Aug 1982 A
4346715 Gammell Aug 1982 A
4375220 Matvias Mar 1983 A
4409993 Furihata Oct 1983 A
4411266 Cosman Oct 1983 A
4418692 Guay Dec 1983 A
4461283 Doi Jul 1984 A
4506680 Stokes Mar 1985 A
4512762 Spears Apr 1985 A
4524770 Orandi Jun 1985 A
4532924 Auth et al. Aug 1985 A
4545368 Rand et al. Oct 1985 A
RE32057 LeVeen Dec 1985 E
RE32066 Leveen Jan 1986 E
4562838 Walker Jan 1986 A
4565200 Cosman Jan 1986 A
4574782 Borrelli et al. Mar 1986 A
4583556 Hines et al. Apr 1986 A
4586490 Katz May 1986 A
4601296 Yerushalmi Jul 1986 A
4648892 Kittrell et al. Mar 1987 A
4652257 Chang Mar 1987 A
4658819 Harris et al. Apr 1987 A
4660571 Hess et al. Apr 1987 A
4662359 Gordon May 1987 A
4676258 Inokuchi et al. Jun 1987 A
4690130 Mirell Sep 1987 A
4692139 Stiles Sep 1987 A
4709701 Weber Dec 1987 A
4753248 Engler et al. Jun 1988 A
4763671 Goffinet Aug 1988 A
4776086 Kasevich et al. Oct 1988 A
4800899 Elliott Jan 1989 A
4813429 Eshel et al. Mar 1989 A
4818542 DeLuca et al. Apr 1989 A
4823791 D'Amelio et al. Apr 1989 A
4823793 Angulo et al. Apr 1989 A
4825880 Stauffer et al. May 1989 A
4838265 Cosman et al. Jun 1989 A
4846196 Wiksell et al. Jul 1989 A
4860744 Johnson et al. Aug 1989 A
4862887 Weber et al. Sep 1989 A
4881543 Trembly et al. Nov 1989 A
4887614 Shirakami et al. Dec 1989 A
4907589 Cosman Mar 1990 A
4920978 Colvin May 1990 A
4931047 Broadwin et al. Jun 1990 A
4940064 Desai Jul 1990 A
4945912 Langberg Aug 1990 A
4947842 Marchosky et al. Aug 1990 A
4950267 Ishihara et al. Aug 1990 A
4962761 Golden Oct 1990 A
4963364 Fox et al. Oct 1990 A
4966604 Reiss Oct 1990 A
4976680 Hayman et al. Dec 1990 A
4976711 Parins et al. Dec 1990 A
4983159 Rand Jan 1991 A
4985022 Fearnot et al. Jan 1991 A
4989601 Marchosky et al. Feb 1991 A
5003991 Takayama et al. Apr 1991 A
5007908 Rydell Apr 1991 A
5009656 Reimels Apr 1991 A
5010897 Leveen Apr 1991 A
5011483 Sleister Apr 1991 A
5013312 Parins et al. May 1991 A
5015227 Broadwin et al. May 1991 A
5016615 Driller et al. May 1991 A
5026959 Ito et al. Jun 1991 A
5047027 Rydell Sep 1991 A
5055100 Olsen Oct 1991 A
5057107 Parins et al. Oct 1991 A
5059199 Okada et al. Oct 1991 A
5067952 Gudov et al. Nov 1991 A
5071419 Rydell et al. Dec 1991 A
5078717 Parins et al. Jan 1992 A
5080660 Buelna Jan 1992 A
5083565 Parins Jan 1992 A
5084001 Van't Hooft et al. Jan 1992 A
5084045 Helenowski Jan 1992 A
5085659 Rydell Feb 1992 A
5099756 Franconi et al. Mar 1992 A
5100423 Fearnot Mar 1992 A
5115818 Holleman et al. May 1992 A
5119832 Xavier Jun 1992 A
5122137 Lennox Jun 1992 A
5125928 Parins et al. Jun 1992 A
5128147 Leveen et al. Jul 1992 A
RE34086 George Oct 1992 E
5156151 Imran Oct 1992 A
5167626 Casper et al. Dec 1992 A
5169396 Dowlatshahi et al. Dec 1992 A
5170789 Narayan et al. Dec 1992 A
5170805 Kensey et al. Dec 1992 A
5178620 Eggers et al. Jan 1993 A
5183455 Hayman et al. Feb 1993 A
5190517 Zieve et al. Mar 1993 A
5190539 Fletcher et al. Mar 1993 A
5190541 Abele et al. Mar 1993 A
5190766 Ishihara Mar 1993 A
5197466 Marchosky et al. Mar 1993 A
5197963 Parins Mar 1993 A
5197964 Parins Mar 1993 A
5203353 Easley et al. Apr 1993 A
5203782 Gudov et al. Apr 1993 A
5205289 Hardy et al. Apr 1993 A
5207675 Canady May 1993 A
5215103 Desai Jun 1993 A
5217458 Parins Jun 1993 A
5222953 Dowlatshahi Jun 1993 A
5236410 Granov et al. Aug 1993 A
5236424 Imran Aug 1993 A
5246438 Langberg Sep 1993 A
5249585 Turner et al. Oct 1993 A
5251645 Fenn Oct 1993 A
5252922 Larson, III Oct 1993 A
5257451 Edwards et al. Nov 1993 A
5258006 Rydell et al. Nov 1993 A
5259394 Bens Nov 1993 A
5259395 Li Nov 1993 A
5267994 Gentelia et al. Dec 1993 A
5273535 Edwards et al. Dec 1993 A
5275162 Edwards et al. Jan 1994 A
5277696 Hagen Jan 1994 A
5281213 Milder et al. Jan 1994 A
5281217 Edwards et al. Jan 1994 A
5281218 Imran Jan 1994 A
5282797 Chess Feb 1994 A
5286253 Fucci Feb 1994 A
5290286 Parins Mar 1994 A
5293869 Edwards et al. Mar 1994 A
5295955 Rosen et al. Mar 1994 A
5300068 Rosar et al. Apr 1994 A
5300069 Hunsberger et al. Apr 1994 A
5300099 Rudie Apr 1994 A
5304214 DeFord et al. Apr 1994 A
5309910 Edwards et al. May 1994 A
5313943 Houser et al. May 1994 A
5314466 Stern et al. May 1994 A
5322503 Desai Jun 1994 A
5328467 Edwards et al. Jul 1994 A
5334193 Nardella Aug 1994 A
5334206 Daikuzono Aug 1994 A
5336222 Durgin, Jr. et al. Aug 1994 A
5342357 Nardella Aug 1994 A
5348554 Imran et al. Sep 1994 A
5354296 Turkel Oct 1994 A
5363861 Edwards et al. Nov 1994 A
5365926 Desai Nov 1994 A
5366490 Edwards et al. Nov 1994 A
5368592 Stern et al. Nov 1994 A
5370675 Edwards et al. Dec 1994 A
5370678 Edwards et al. Dec 1994 A
5383876 Nardella Jan 1995 A
5383917 Desai et al. Jan 1995 A
5385544 Edwards et al. Jan 1995 A
5397339 Desai Mar 1995 A
5398683 Edwards et al. Mar 1995 A
5401272 Perkins Mar 1995 A
5403311 Abele et al. Apr 1995 A
5405346 Grundy et al. Apr 1995 A
5409453 Lundquist et al. Apr 1995 A
5411025 Webster, Jr. May 1995 A
5417687 Nardella May 1995 A
5421819 Edwards et al. Jun 1995 A
5423807 Milder Jun 1995 A
5423808 Edwards et al. Jun 1995 A
5423811 Imran et al. Jun 1995 A
5433708 Nichols et al. Jul 1995 A
5435805 Edwards et al. Jul 1995 A
5437662 Nardella Aug 1995 A
5437664 Cohen et al. Aug 1995 A
5456662 Edwards et al. Oct 1995 A
5456682 Edwards et al. Oct 1995 A
5458596 Lax et al. Oct 1995 A
5458597 Edwards et al. Oct 1995 A
5462521 Brucker et al. Oct 1995 A
5470308 Edwards et al. Nov 1995 A
5470309 Edwards et al. Nov 1995 A
5471982 Edwards et al. Dec 1995 A
5472441 Edwards et al. Dec 1995 A
5484400 Edwards et al. Jan 1996 A
5486161 Lax et al. Jan 1996 A
5500012 Brucker et al. Mar 1996 A
5505730 Edwards Apr 1996 A
5507743 Edwards et al. Apr 1996 A
5509419 Edwards et al. Apr 1996 A
5514130 Baker May 1996 A
5514131 Edwards May 1996 A
5520684 Imran May 1996 A
5531676 Edwards et al. Jul 1996 A
5531677 Lundquist et al. Jul 1996 A
5536240 Edwards et al. Jul 1996 A
5536267 Edwards et al. Jul 1996 A
5540655 Edwards et al. Jul 1996 A
5542915 Edwards et al. Aug 1996 A
5542916 Hirsch et al. Aug 1996 A
5542928 Evans et al. Aug 1996 A
5545161 Imran Aug 1996 A
5545171 Sharkey et al. Aug 1996 A
5545193 Fleischman et al. Aug 1996 A
5546267 Frederiksen et al. Aug 1996 A
5548597 Kayama et al. Aug 1996 A
5549108 Edwards et al. Aug 1996 A
5549644 Lundquist et al. Aug 1996 A
5554110 Edwards et al. Sep 1996 A
5556377 Rosen et al. Sep 1996 A
5558672 Edwards et al. Sep 1996 A
5558673 Edwards et al. Sep 1996 A
5560358 Arnold et al. Oct 1996 A
5562703 Desai Oct 1996 A
5599345 Edwards et al. Feb 1997 A
5599346 Edwards et al. Feb 1997 A
5609151 Mulier et al. Mar 1997 A
5620481 Desai et al. Apr 1997 A
5685839 Edwards et al. Nov 1997 A
5817092 Behl Oct 1998 A
5827276 LeVeen et al. Oct 1998 A
Foreign Referenced Citations (20)
Number Date Country
2124684 Nov 1972 DE
0 370 890 May 1990 EP
0 462 302 Dec 1991 EP
0 472 368 Feb 1992 EP
0 502 268 Sep 1992 EP
0 519 415 Dec 1992 EP
0 608 609 Aug 1994 EP
WO 9210142 Jun 1992 WO
WO 9404220 Mar 1994 WO
WO 9410925 May 1994 WO
WO 9411059 May 1994 WO
WO 9417856 Aug 1994 WO
WO 9425110 Nov 1994 WO
WO 9426178 Nov 1994 WO
WO 9519142 Jul 1995 WO
WO 9525471 Sep 1995 WO
WO 9604860 Feb 1996 WO
WO 9629946 Oct 1996 WO
WO 9706739 Feb 1997 WO
WO 9706855 Feb 1997 WO
Continuation in Parts (4)
Number Date Country
Parent 08605323 Feb 1996 US
Child 08963239 US
Parent 08515379 Aug 1995 US
Child 08605323 US
Parent 08290031 Aug 1994 US
Child 08515379 US
Parent 08148439 Nov 1993 US
Child 08290031 US